Unlocking Affordability: The FDA's Bold Play to Turbocharge Generic Drug Access

The Looming Storm: How Trade Tensions Could Reshape the World's Pharmacy

The Great Pivot: How Cipla is Betting Big on the Future of Health, Chronic Care, and Yes, Even Obesity

The Quiet Revolution: How the FDA is Finally Taking Aim at Sky-High Drug Prices

The Quiet Revolution: How Federal Officials Are Fighting for Cheaper Biotech Drugs

Unlocking Access: The FDA's Bold Move to Fast-Track Life-Saving Biosimilars

A New Frontier? Dr. Reddy's, The Weight Loss Revolution, And The Billions At Stake

The Big Play: Dr. Reddy's Bets on a Trio of Launches to Outmaneuver US Market Erosion

The Shadow Returns: What Trump's Drug Pricing Encore Means for Your Medicine Cabinet

The Great Pharmaceutical Reversal: Onshoring's Costly Gamble with Drug Affordability

Trump's Tariff Threat Looms: How India's Pharma Giants Brace for a 100% Import Duty Shake-up

Celltrion Fortifies Biologics Dominance with Strategic Eli Lilly Plant Acquisition

South Korean Pharma Giant Celltrion Seals $330M Deal for Eli Lilly's U.S. Biologics Facility

Alkem Laboratories Unveils 'Perjio': A Landmark Leap in Affordable Breast Cancer Treatment in India

The Dawn of a New Era: Keytruda's Patent Cliff and the Future of Cancer Care